Monoclonal Antibody for Breast/Stomach Cancer
Created 2 weeks ago by anniepery

Trastuzumab (Herceptin), specifically is a monoclonal antibody approved in order to treat breast and stomach cancer. It is used for cancer that is HER2 receptor-positive. The trastuzumab 440 mg may be used by itself or along with other chemotherapy drugs. It is administered by slow injection into a vein and injection under the skin. Fever, cough, infection, headache, rash, and trouble sleeping are the commonly reported side effects due to trastuzumab. Certain other severe side effects include allergic reactions, heart failure, and lung disease. Trastuzumab use during pregnancy may be responsible for causing harm to the baby.